86 related articles for article (PubMed ID: 22798680)
1. CD4+ T cells disarm or delete cytotoxic T lymphocytes under IL-17-polarizing conditions.
Tsai JP; Lee MH; Hsu SC; Chen MY; Liu SJ; Chang JT; Liao CT; Cheng AJ; Chong P; Chu CL; Shen CR; Chen HW
J Immunol; 2012 Aug; 189(4):1671-9. PubMed ID: 22798680
[TBL] [Abstract][Full Text] [Related]
2. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.
Tajima M; Wakita D; Satoh T; Kitamura H; Nishimura T
Int Immunol; 2011 Dec; 23(12):751-9. PubMed ID: 22039016
[TBL] [Abstract][Full Text] [Related]
3. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
[TBL] [Abstract][Full Text] [Related]
4. Changes of Th17/Tc17 and Th17/Treg cells in endometrial carcinoma.
Zhang W; Hou F; Zhang Y; Tian Y; Jiao J; Ma D; Kong B; Cui B
Gynecol Oncol; 2014 Mar; 132(3):599-605. PubMed ID: 24388919
[TBL] [Abstract][Full Text] [Related]
5. Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients.
Kuang DM; Peng C; Zhao Q; Wu Y; Zhu LY; Wang J; Yin XY; Li L; Zheng L
J Immunol; 2010 Aug; 185(3):1544-9. PubMed ID: 20581151
[TBL] [Abstract][Full Text] [Related]
6. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
[TBL] [Abstract][Full Text] [Related]
7. CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer.
Zhuang Y; Peng LS; Zhao YL; Shi Y; Mao XH; Chen W; Pang KC; Liu XF; Liu T; Zhang JY; Zeng H; Liu KY; Guo G; Tong WD; Shi Y; Tang B; Li N; Yu S; Luo P; Zhang WJ; Lu DS; Yu PW; Zou QM
Gastroenterology; 2012 Oct; 143(4):951-62.e8. PubMed ID: 22710190
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of interleukin-17-producing CD4(+) tumor infiltrating lymphocytes in human oral squamous cell carcinoma.
Lee JJ; Chang YL; Lai WL; Ko JY; Kuo MY; Chiang CP; Azuma M; Chen CW; Chia JS
Head Neck; 2011 Sep; 33(9):1301-8. PubMed ID: 21837700
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E
Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488
[TBL] [Abstract][Full Text] [Related]
10. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
11. Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment.
Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
Cancer Immunol Immunother; 2007 Sep; 56(9):1429-42. PubMed ID: 17265021
[TBL] [Abstract][Full Text] [Related]
12. Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis.
Egan PJ; van Nieuwenhuijze A; Campbell IK; Wicks IP
Arthritis Rheum; 2008 Dec; 58(12):3720-9. PubMed ID: 19035489
[TBL] [Abstract][Full Text] [Related]
13. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
Mol Ther; 2006 Jan; 13(1):183-93. PubMed ID: 16125469
[TBL] [Abstract][Full Text] [Related]
14. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
15. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
Cancer Res; 2007 Sep; 67(18):8865-73. PubMed ID: 17875728
[TBL] [Abstract][Full Text] [Related]
16. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
[TBL] [Abstract][Full Text] [Related]
17. Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6.
Liu SJ; Tsai JP; Shen CR; Sher YP; Hsieh CL; Yeh YC; Chou AH; Chang SR; Hsiao KN; Yu FW; Chen HW
J Leukoc Biol; 2007 Aug; 82(2):354-60. PubMed ID: 17505023
[TBL] [Abstract][Full Text] [Related]
18. Neutralization of IL-4 reverses the nonresponsiveness of CD4+ T cells to regulatory T-cell induction in non-responder mouse strains.
Wang J; Han WG; Foks AC; Huizinga TW; Toes RE
Mol Immunol; 2010; 48(1-3):137-46. PubMed ID: 20869773
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
20. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction.
Trzonkowski P; Szmit E; Myśliwska J; Dobyszuk A; Myśliwski A
Clin Immunol; 2004 Sep; 112(3):258-67. PubMed ID: 15308119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
